<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-metsera-acquisition-architect-swings-structure" hreflang="en">Chutes & Ladders—Metsera acquisition architect swings to Structure</a>
fiercebiotech.com·Apr 16, 2026
Matthew Lang has transitioned to Structure Therapeutics as chief operating officer and general counsel after successfully guiding Metsera through its $10 billion acquisition by Pfizer.
For someone tracking healthtech and biotech, the key learning here is the strategic move of Matthew Lang to Structure Therapeutics, highlighting potential growth or significant initiatives in the obesity biotech space. This could signal an opportunity for investment or partnership, especially considering Lang's successful track record with Metsera's acquisition by Pfizer.